GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Shares Buyback Ratio %

Hemagen Diagnostics (Hemagen Diagnostics) Shares Buyback Ratio % : -0.10 (As of Jun. 09, 2024)


View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Hemagen Diagnostics's current shares buyback ratio was -0.10%.


Hemagen Diagnostics Shares Buyback Ratio % Historical Data

The historical data trend for Hemagen Diagnostics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Shares Buyback Ratio % Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.13 -2.10 -0.13 -0.10

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 0.61 -0.68 -0.03 -

Hemagen Diagnostics Shares Buyback Ratio % Calculation

Hemagen Diagnostics's Shares Buyback Ratio for the fiscal year that ended in Sep. 2012 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Sep. 2011 ) - Shares Outstanding (EOP) (A: Sep. 2012 )) / Shares Outstanding (EOP) (A: Sep. 2011 )
=(15.5853 - 15.6003) / 15.5853
=-0.10%

Hemagen Diagnostics's Shares Buyback Ratio for the quarter that ended in Sep. 2012 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2012 ) - Shares Outstanding (EOP) (A: Sep. 2012 )) / Shares Outstanding (EOP) (A: Jun. 2012 )
=(15.6003 - 15.6003) / 15.6003
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hemagen Diagnostics Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Executives
Howard F Curd director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines